Powered by: Motilal Oswal

News

Jubilant Ingrevia soars on raising Rs 100 crore via commercial papers Jubilant Ingrevia is currently trading at Rs. 404.70, up by 6.35 points or 1.59% from its previous closing of Rs. 398.35 on the BSE. The scrip opened at Rs. 400.00 and has touched a high and low of Rs. 405.70 and Rs. 397.85 respectively. So far 2849 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 350.80 on 29-Mar-2023. Last one week high and low of the scrip stood a...
Jubilant Ingrevia soars on raising Rs 100 crore via commercial papers
Jubilant Ingrevia soars on raising Rs 100 crore via commercial papers
Source: Accord Fintech
29/05/2023 10:07:12 AM
India`s Jubilant Ingrevia posts Q4 profit slump as supplements faced headwinds India's Jubilant Ingrevia Ltd on Tuesday reported an almost 24% slump in fourth-quarter profit as lower chemicals price and sustained challenges in the supplements business dented revenue. Consolidated net profit fell to 523.1 million rupees ($6.4 million) for the three months ended March 31 from 685.9 million rupees a year earlier, marking the fourth straight quarter of earnings drop. Margins on the earnings before interest, taxes, depreciation and amortisation (EBITDA) shrank to 9...
India`s Jubilant Ingrevia posts Q4 profit slump as supplements faced headwinds
India`s Jubilant Ingrevia posts Q4 profit slump as supplements faced headwinds
Source: Reuters
16/05/2023 5:54:24 PM
Jubilant Ingrevia gains on raising Rs 50 crore via commercial papers Jubilant Ingrevia is currently trading at Rs. 431.20, up by 1.25 points or 0.29% from its previous closing of Rs. 429.95 on the BSE. The scrip opened at Rs. 430.05 and has touched a high and low of Rs. 434.35 and Rs. 428.00 respectively. So far 7178 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 350.80 on 29-Mar-2023. Last one week high and low of the scrip stood a...
Jubilant Ingrevia gains on raising Rs 50 crore via commercial papers
Jubilant Ingrevia gains on raising Rs 50 crore via commercial papers
Source: Accord Fintech
9/05/2023 10:51:11 AM
Jubilant Ingrevia gains on commissioning new Acetic Anhydride plant in Gujarat Jubilant Ingrevia is currently trading at Rs. 401.45, up by 2.85 points or 0.72% from its previous closing of Rs. 398.60 on the BSE. The scrip opened at Rs. 398.60 and has touched a high and low of Rs. 404.75 and Rs. 388.85 respectively. So far 34547 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 350.80 on 29-Mar-2023. Last one week high and low of the scrip stood ...
Jubilant Ingrevia gains on commissioning new Acetic Anhydride plant in Gujarat
Jubilant Ingrevia gains on commissioning new Acetic Anhydride plant in Gujarat
Source: Accord Fintech
17/04/2023 2:39:57 PM
Jubilant Ingrevia moves higher on acquiring 37.98% stake in Mister Veg Foods Jubilant Ingrevia is currently trading at Rs. 412.90, up by 15.60 points or 3.93% from its previous closing of Rs. 397.30 on the BSE. The scrip opened at Rs. 400.45 and has touched a high and low of Rs. 420.20 and Rs. 400.45 respectively. So far 13370 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 395.65 on 16-Mar-2023. Last one week high and low of the scrip stood...
Jubilant Ingrevia moves higher on acquiring 37.98% stake in Mister Veg Foods
Jubilant Ingrevia moves higher on acquiring 37.98% stake in Mister Veg Foods
Source: Accord Fintech
17/03/2023 11:07:10 AM
Jubilant Ingrevia gains on raising Rs 150 crore via CPs Jubilant Ingrevia is currently trading at Rs. 469.50, up by 0.55 points or 0.12% from its previous closing of Rs. 468.95 on the BSE. The scrip opened at Rs. 467.20 and has touched a high and low of Rs. 476.00 and Rs. 465.10 respectively. So far 73755 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 401.35 on 08-Mar-2022. Last one week high and low of the scrip stood ...
Jubilant Ingrevia gains on raising Rs 150 crore via CPs
Jubilant Ingrevia gains on raising Rs 150 crore via CPs
Source: Accord Fintech
13/02/2023 3:50:34 PM
Diwali Fundamental Muhurat Picks By Angel One Federal Bank * Federal bank is one of India's largest old generation private sector banks. At the end of Q2 FY2023 the bank had advances of Rs. 1.61 lakh cr. And deposits of Rs 1.89 lakh cr. The bank predominantly has a secured lending book which helped limit asset quality issues during the Covid 19 pandemic. * Federal Bank has posted a good set of numbers for Q2FY23 as NII, and Advances increased by 19.1%/19.9% YoY. Provisioning for the quarter was up by mere 9% YoY because of whic...
Diwali Fundamental Muhurat Picks By Angel One
Diwali Fundamental Muhurat Picks By Angel One
Source: Angel One Ltd
22/10/2022 2:06:16 PM
Jubilant Ingrevia surges on raising Rs 50 crore via CPs Jubilant Ingrevia is currently trading at Rs. 474.90, up by 3.55 points or 0.75% from its previous closing of Rs. 471.35 on the BSE. The scrip opened at Rs. 468.00 and has touched a high and low of Rs. 483.90 and Rs. 467.75 respectively. So far 18256 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 877.95 on 18-Oct-2021 and a 52 week low of Rs. 401.35 on 08-Mar-2022. Last one week high and low of the scrip stood ...
Jubilant Ingrevia surges on raising Rs 50 crore via CPs
Jubilant Ingrevia surges on raising Rs 50 crore via CPs
Source: Accord Fintech
1/09/2022 12:33:20 PM
Jubilant Ingrevia raises Rs 25 crore through Commercial Papers Jubilant Ingrevia has raised Rs 25 crore through Commercial Papers (CPs) on July 15, 2022. Date of maturity of said Commercial Papers will be August 30, 2022. Tenure of the instrument of this Commercial Papers is 46 days. Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
Jubilant Ingrevia raises Rs 25 crore through Commercial Papers
Jubilant Ingrevia raises Rs 25 crore through Commercial Papers
Source: Accord Fintech
18/07/2022 10:20:21 AM
Jubilant Ingrevia Q4 net profit jumps 93.00% at Rs 74.48 cr The company reported standalone net profit of Rs 74.48 crore for the quarter ended March 31, 2022 as compared to Rs 38.59 crore in the same period last year, registering a year-on-year growth of 93.00 per cent. Net revenue of the company rose substantially by 87.97 per cent at Rs 1,247.69 crore in January-March quarter of this fiscal as against Rs 663.77 crore in the corresponding period last year. During January-March quarter, operating expenses increased by 93.35 per cent to Rs 1,106.15 ...
Jubilant Ingrevia Q4 net profit jumps 93.00% at Rs 74.48 cr
Jubilant Ingrevia Q4 net profit jumps 93.00% at Rs 74.48 cr
Source: Dion Global Solutions Ltd
18/05/2022 1:35:34 PM
Buy Jubilant Ingrevia Ltd For Target Rs.1040 - Monarch Networth Capital Jubilant Ingrevia (‘Ingrevia’) came out with its Q2FY22 results, which showed significant QoQ de-growth in absolute EBITDA and margins on the back Acetyls (LS Chem EBITDA 14% vs 27% QoQ). Large part of sequential decline was on account of Inventory gains in Q1FY22 and reduction in % spreads. As per us, Q2FY22 can be considered as base for absolute EBITDA in acetyls while the margins may continue to decline on the back of higher Acetic acid prices. Spec Chem margins declined on the...
Buy Jubilant Ingrevia Ltd For Target Rs.1040 - Monarch Networth Capital
Buy Jubilant Ingrevia Ltd For Target Rs.1040 - Monarch Networth Capital
Source: Monarch Networth Capital Ltd
21/10/2021 5:45:24 PM
Update On Jubilant Ingrevia Ltd By HDFC Securities Our Take: Jubilant Ingrevia has presence across mainly three segments Speciality Chemicals (33% of revenue), Nutrition and Health Solutions (18%) and Life Science Chemicals (49%), with strong backward integration and a leading market position. About 25% of Life Science Chemicals (LSC) volumes and 45% of pyridine and picolines (speciality chemicals) are consumed in house, leading to retaining of higher profit across the value chain. During FY21, the company derived about 54% of its revenue ...
Update On Jubilant Ingrevia Ltd By HDFC Securities
Update On Jubilant Ingrevia Ltd By HDFC Securities
Source: HDFC Securities
30/09/2021 12:24:36 PM
Key News - Jubilant Ingrevia Ltd, Mindtree, Hero Electric, Axis Bank By ARETE Securities Key News Restructuring plan: Ford India talks up compensation with dealer partners Ford India on Wednesday met its principal dealers to work out a compensation formula as it prepares to exit India's automobile market as part of a restructuring it announced on September 9. Most of the company's 170 dealers signed a non-disclosure agreement – a precondition set by the company to start negotiations. The day-long meeting hosted by Anurag Mehrotra, Ford India managing director,...
Key News - Jubilant Ingrevia Ltd, Mindtree, Hero Electric, Axis Bank By ARETE Securities
Key News - Jubilant Ingrevia Ltd, Mindtree, Hero Electric, Axis Bank By ARETE Securities
Source: ARETE Securities Ltd
23/09/2021 10:01:20 AM
Emargin Positional Pick Buy Jubilant Ingrevia Ltd For Target Rs. 950 - HDFC Securities  Emargin Positional Pick Buy Jubilant Ingrevia Ltd For Target Rs. 950 - HDFC Securities  TECHNICAL OBSERVATIONS * Stock price has broken out on the daily chart with higher volumes. * Stock price is forming bullish higher top higher bottom formation on the daily and weekly chart. * Short term trend of the Stock is positive where it is trading above its 5 and 20 day EMA * RSI oscillator is placed above 60 and rising upwards, Indicating strength in the...
Emargin Positional Pick Buy Jubilant Ingrevia Ltd For Target Rs. 950 - HDFC Securities 
Emargin Positional Pick Buy Jubilant Ingrevia Ltd For Target Rs. 950 - HDFC Securities 
Source: HDFC Securities Ltd
14/09/2021 2:42:10 PM
Buy Jubilant Ingrevia Ltd For Target Rs.770 - Monarch Networth Capital Key Meeting Takeaways Specialty segment: * CDMO Expansion: Multiproduct facility for Pharma & Crop Protection customers, diketene derivatives and agro actives ( for pesticides) will start in the next 2 years with capex of ~Rs 550cr years in 3 years’ time. Growth will be higher and margins are expected to improve in 3-5 years’ time in the segment.   Nutrition & Health solutions: * Expand Vitamin B3 capacity by ~20% from current 13,000 MT/ Year and launch...
Buy Jubilant Ingrevia Ltd For Target Rs.770 - Monarch Networth Capital
Buy Jubilant Ingrevia Ltd For Target Rs.770 - Monarch Networth Capital
Source: Monarch Networth Capital Ltd
20/08/2021 11:56:43 AM
Technical Positional Pick - Buy Jubilant Ingrevia Ltd For Target Rs. 800 - HDFC Securities Technical Positional Pick - Buy Jubilant Ingrevia Ltd For Target Rs. 800 - HDFC Securities  TECHNICAL OBSERVATIONS * Stock price has broken out on the daily chart with higher volumes. * Short term trend of the stock is positive where it is trading above its 5 and 20 and 50 day EMA. * Oscillators like RSI and MFI is showing strength in the stock. * Plus DI is trading above Minus DI, Indicating strength in the current uptrend. * Considering the Technic...
Technical Positional Pick - Buy Jubilant Ingrevia Ltd For Target Rs. 800 - HDFC Securities
Technical Positional Pick - Buy Jubilant Ingrevia Ltd For Target Rs. 800 - HDFC Securities
Source: HDFC Securities Ltd
9/08/2021 12:19:05 PM
Buy Jubilant Ingrevia Ltd For Target Rs.770 - Monarch Networth First Cut: Extremely encouraging performance on the back of Acetyls and Specialty Segment  Ingrevia trades at ~11.4x FY23E EV/EBITDA. Given that Specialty and Nutrition business contributes >70% of our FY23E EBITDA, we believe there is room for further re-rating * Financial Performance - Sales at INR 1145crs up 6% QoQ / 55% YoY - EBITDA at INR 287crs up 43% QoQ / 126% YoY - EBITDA margins 25% vs 19% QoQ - Inventory gains of INR ~63crs; adjusting which EBITDA margins at 20% ...
Buy Jubilant Ingrevia Ltd For Target Rs.770 - Monarch Networth
Buy Jubilant Ingrevia Ltd For Target Rs.770 - Monarch Networth
Source: Monarch Networth Capital Ltd
21/07/2021 10:01:47 AM
Quote on Jubilant Ingrevia Ltd -1QFY22 - Result Update By Mr. Amarjeet Maurya, Angel Broking Ltd Below are Quote on Jubilant Ingrevia Ltd -1QFY22 - Result Update by Mr. Amarjeet Maurya, AVP - Mid Caps, Angel Broking Ltd Jubilant Ingrevia Ltd (JIL) 1QFY2022 results outperformed the estimates. The top-line grew by ~55% YoY to Rs1,145cr on the back of robust growth in volume and prices. On segment wise,  Speciality Chemicals revenue grew by ~18% yoy, Nutrition and Health Solutions revenue grew by ~13% yoy and Life Sciences Chemical revenue grew by ~103% yoy.On the EBI...
Quote on Jubilant Ingrevia Ltd -1QFY22 - Result Update By Mr. Amarjeet Maurya, Angel Broking Ltd
Quote on Jubilant Ingrevia Ltd -1QFY22 - Result Update By Mr. Amarjeet Maurya, Angel Broking Ltd
Source: Angel Broking Ltd
20/07/2021 3:31:41 PM